A. Grigg

发表

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome

R. D'Andrea, A. Wei, A. Dear, 2014, Blood Cancer Journal.

Variability in determination of body weight used for dosing busulphan and cyclophosphamide in adult patients: results of an international survey.

J. Szer, A. Grigg, M. H. Harun, 1997, Leukemia & lymphoma.

Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders

J. Szer, A. Roberts, K. Bradstock, 2006, Bone Marrow Transplantation.

Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders.

J. Szer, J. Seymour, R. Fox, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir

J. Szer, J. Matthews, J. Sasadeusz, 2000, Bone Marrow Transplantation.

Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy

J. Szer, K. Thursky, L. Ling, 2008, Internal medicine journal.

Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: A Prospective Australasian Leukaemia and Lymphoma Group Study

J. Szer, D. Roos, A. Wirth, 2005, Bone Marrow Transplantation.

Intermediate dose cyclophosphamide combined with a growth factor is a safe and effective regimen for mobilisation of peripheral blood progenitor cells.

J. Szer, A. Grigg, G. Goss, 1996, Australian and New Zealand Journal of Medicine.

G-CSF stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis.

J. Szer, P. Bardy, A. Grigg, 1996, Australian and New Zealand journal of medicine.

Combined chemotherapy and granulocyte colony-stimulating factor (G-CSF) mobilise large numbers of peripheral blood progenitor cells in pretreated patients.

C. Begley, J. Szer, A. Boyd, 1994, Leukemia & lymphoma.

Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3

R. Gascoyne, D. Horsman, G. Phillips, 1993, British journal of haematology.

Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine

J. Matthews, H. Prince, J. Seymour, 2004, Leukemia.

Disseminated fungal infection and early onset microangiopathy after allogeneic bone marrow transplantation.

A. Grigg, D. Clouston, 1995, Bone marrow transplantation.

Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX

J. Szer, D. Ritchie, A. Grigg, 2010, Bone Marrow Transplantation.

Pamidronate reduces bone loss after allogeneic stem cell transplantation.

R. Herrmann, J. Szer, P. Ebeling, 2006, The Journal of clinical endocrinology and metabolism.

Factors influencing the outcome of donor marrow transplantation in adults from less than ideal donors: experience from two Australian centres.

J. Szer, P. Bardy, A. Grigg, 1997, Australian and New Zealand journal of medicine.

G-CSF stimulated donor granulocyte collections for neutropenic sepsis.

J. Szer, A. Grigg, J. Lusk, 1995, Leukemia & lymphoma.

Consensus guidelines for the use of empiric and diagnostic‐driven antifungal treatment strategies in haematological malignancy, 2014

S. Kirsa, N. Gilroy, T. Gottlieb, 2014, Internal medicine journal.

Prolonged Disease-Free Survival after Autografting for Chemosensitive Non-Bulky Low Grade Non-Hodgkin's Lymphoma

J. Szer, A. Grigg, A. Grigg, 2000, Leukemia & lymphoma.

The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

J. Szer, A. Roberts, H. Prince, 2006, Annals of Hematology.

Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management

J. Szer, D. Zantomio, Y. Panek-Hudson, 2006, Bone Marrow Transplantation.

Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation

G. Byrnes, J. Szer, K. Thursky, 2004, Bone Marrow Transplantation.

Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy

G. Byrnes, J. Szer, A. Grigg, 2000, Bone Marrow Transplantation.

Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine

J. Szer, R. Chapman, A. Grigg, 1998, Bone Marrow Transplantation.

Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants

J. Szer, R. Abraham, P. Bardy, 1997, Bone Marrow Transplantation.

Multiple granulocyte transfusions facilitating successful unrelated bone marrow transplantation in a patient with very severe aplastic anemia complicated by suspected fungal infection.

J. Szer, D. Coghlan, A. Grigg, 1995, Bone marrow transplantation.

Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants

J. Szer, A. Roberts, D. Curtis, 2008, Bone Marrow Transplantation.

Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield

S. Lade, J. Seymour, C. Stern, 2006, British Journal of Cancer.

Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg)

J. Szer, A. Grigg, R. McLachlan, 2000, Bone Marrow Transplantation.

Hansenula anomala infection after bone marrow transplantation.

M. Slavin, A. Grigg, G. Goss, 1994, Bone marrow transplantation.

The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia

Erinna F. Lee, W. D. Fairlie, J. Szer, 2009, Leukemia.

Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine

J. Reynolds, C. Hui, K. Bradstock, 2005, Leukemia and Lymphoma.

Liver failure complicating non-alcoholic steatohepatitis following allogeneic bone marrow transplantation for Shwachman–Diamond syndrome

P. Bhathal, A. Grigg, P. Angus, 2002, Bone Marrow Transplantation.

Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR

L. To, A. Trickett, D. Ma, 2003, Leukemia.

Mini-allografts' for haematological malignancies: an alternative to conventional myeloablative marrow transplantation.

J. Szer, J. Seymour, A. Grigg, 1999, Australian and New Zealand journal of medicine.

Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma

J. Szer, J. Seymour, P. Bardy, 1999, Bone Marrow Transplantation.

Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells

J. Szer, A. Grigg, R. Hoyt, 2000, Bone Marrow Transplantation.

Prolonged disease-free survival with specific re-induction therapy in acute myeloid leukaemia relapsing following bone marrow transplantation.

J. Szer, J. Seymour, D. Thomas, 1997, Australian and New Zealand journal of medicine.

Peyronie's Disease as a Complication of Chronic Graft versus Host Disease

C. Underhill, A. Grigg, G. Sale, 2002, Hematology.

Pure red cell aplasia with the onset of graft versus host disease

A. Grigg, S. Juneja, Andrew P Grigg, 2003, Bone Marrow Transplantation.

Case report Pure red cell aplasia with the onset of graft versus host disease

A. Grigg, S. Juneja, 2003 .

IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD

A. Lyon, J. Storek, J. Russell, 2013, Bone Marrow Transplantation.

Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without increasing relapse

J. Storek, A. Grigg, J. Russell, 2013, Bone Marrow Transplantation.

A phase I dose-escalation study of etoposide continuous infusion added to busulphan/cyclophosphamide as conditioning prior to autologous or allogeneic stem cell transplantation

J. Szer, A. Grigg, P. Shuttleworth, 2002, Bone Marrow Transplantation.

Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation

L. Mileshkin, J. Biagi, H. Prince, 2001, Bone Marrow Transplantation.

Failure of engraftment of lenograstim mobilised allogeneic peripheral blood progenitor cells in aplastic anaemia.

J. Szer, A. Grigg, G. Goss, 1994, Australian and New Zealand journal of medicine.

Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid difference.

J. Szer, M. Varney, B. Tait, 1997, Human immunology.

Acute left ventricular failure following melphalan and fludarabine conditioning

J. Szer, J. Seymour, A. Grigg, 2001, Bone Marrow Transplantation.

Autografting followed by rituximab for chemosensitive mantle cell lymphoma: A pilot study and literature review

P. Marlton, J. Seymour, D. Gill, 2005, Leukemia & lymphoma.

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

R. Herrmann, D. Joske, J. Bashford, 2005, Bone Marrow Transplantation.

Clinical relevance of the minor histocompatibility antigen HA-1 in allogeneic bone marrow transplantation between HLA identical siblings.

J. McCluskey, J. Szer, S. Heatley, 2001, Transplantation proceedings.

2′-Deoxycoformycin for Hepatosplenic γδ T-Cell Lymphoma

A. Grigg, Andrew P Grigg, 2001 .

Abnormal cervical cytology in bone marrow transplant recipients

J. Szer, A. Schwarer, J. Sasadeusz, 2001, Bone Marrow Transplantation.

The addition of allogeneic peripheral blood-derived progenitor cells to bone marrow for transplantation: results of a randomised clinical trial.

J. Szer, D. Curtis, P. Bardy, 1999, Australian and New Zealand journal of medicine.

Graft versus Burkitt's Lymphoma Effect after Allogeneic Marrow Transplantation

J. Seymour, J. Seymour, A. Grigg, 2002, Leukemia & lymphoma.

A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation

J. Szer, A. Roberts, K. Thursky, 2007, Bone Marrow Transplantation.

Allogeneic bone marrow transplantation for relapsed acute myeloid leukaemia (AML)

J. Szer, P. Bardy, A. Grigg, 1996, Australian and New Zealand journal of medicine.

Staged autologous peripheral blood progenitor cell transplantation for Ewing sarcoma and rhabdomyosarcoma

J. Szer, M. Rosenthal, D. Ritchie, 2004, Internal medicine journal (Print).

Successful donor leukocyte infusion for chronic myeloid leukemia relapsing in accelerated phase after T cell-replete unrelated marrow transplantation.

J. Szer, A. Grigg, 1996, Bone marrow transplantation.

Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies.

C. Begley, J. Szer, L. To, 1994, Bone marrow transplantation.

The incidence, pathogenesis and natural history of steatorrhoea after bone marrow transplantation

J. Szer, A. Grigg, R. Hoyt, 2003, Bone Marrow Transplantation.

Higher-Dose Imatinib (600 mg/Day) with Selective Intensification in Newly Diagnosed CML Patients in Chronic Phase; Cytogenetic Response Rates at 12 Months Are Superior to IRIS.

J. Reynolds, A. Schwarer, Z. Rudzki, 2004 .

BCR-ABL Levels Continue To Decrease up to 42 Months after Commencement of Standard Dose Imatinib in Patients with Newly Diagnosed Chronic Phase CML Who Achieve a Major Molecular Response.

P. Browett, A. Schwarer, Z. Rudzki, 2004 .

Multi-organ dysfunction associated with high-dose carboplatin therapy prior to autologous transplantation.

J. Szer, K. Skov, A. Grigg, 1996, Bone marrow transplantation.

Passive donor‐to‐recipient transfer of antiphospholipid syndrome following allogeneic stem‐cell transplantation

D. Ritchie, A. D’Souza, A. Grigg, 2005, American journal of hematology.

Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected].

D. Reece, A. Eaves, M. Barnett, 1991, Blood.

HLA-identical sibling peripheral blood cell transplants. The Australian experience and preliminary results of a randomised study.

J. Szer, P. Bardy, A. Grigg, 1998, Bone marrow transplantation.

Hepatitis B reactivation after thalidomide

J. Sasadeusz, A. Grigg, A. Grigg, 2008, Internal medicine journal.